JVMCX
Price
$28.77
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RPMVX
Price
$18.87
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

JVMCX vs RPMVX

Header iconJVMCX vs RPMVX Comparison
Open Charts JVMCX vs RPMVXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.77
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Reinhart Mid Cap PMV Adv
Price$18.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMCX vs RPMVX Comparison Chart
Loading...
VS
JVMCX vs. RPMVX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and RPMVX is a Buy.

FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.1B vs. RPMVX (130M). RPMVX pays higher dividends than JVMCX: RPMVX (0.87) vs JVMCX (0.01). JVMCX was incepted earlier than RPMVX: JVMCX (13 years) vs RPMVX (12 years). RPMVX (42.00) and JVMCX (41.00) have comparable annual turnover. JVMCX has a lower initial minimum investment than RPMVX: JVMCX (1000) vs RPMVX (5000). JVMCX annual gain was more profitable for investors over the last year : 14.99 vs. RPMVX (13.29). JVMCX return over 5 years is better than : 37.53 vs. RPMVX (31.70).
JVMCXRPMVXJVMCX / RPMVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years12 years-
Gain YTD9.33611.30483%
Front LoadN/AN/A-
Min. Initial Investment1000500020%
Min. Initial Investment IRAN/AN/A-
Net Assets23.1B130M17,769%
Annual Yield % from dividends0.010.872%
Returns for 1 year14.9913.29113%
Returns for 3 years7.776.12127%
Returns for 5 years37.5331.70118%
Returns for 10 years47.5534.14139%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAC39.870.47
+1.19%
Camden National Corp
DLB72.680.80
+1.11%
Dolby Laboratories IncClass A
JBLU5.72-0.03
-0.52%
JetBlue Airways Corp
SWIN2.67-0.08
-2.91%
Solowin Holdings Ordinary Share
SEEL0.20-0.03
-11.51%
Seelos Therapeutics Inc.